BioNTech
BNTX
BNTX
283 hedge funds and large institutions have $3.29B invested in BioNTech in 2024 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 84 increasing their positions, 99 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
283
Holders Change
-2
Holders Change %
-0.7%
% of All Funds
4.12%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.09%
New
36
Increased
84
Reduced
99
Closed
36
Calls
$145M
Puts
$137M
Net Calls
+$8.7M
Net Calls Change
+$6.84M
Top Buyers
| 1 |
Flossbach Von Storch
Cologne,
Germany
|
+$73.2M |
| 2 |
Capital International Investors
Los Angeles,
California
|
+$59.7M |
| 3 |
Millennium Management
New York
|
+$37.5M |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$33.6M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$32.9M |
Top Sellers
| 1 |
Temasek Holdings
Singapore
|
-$130M |
| 2 |
HL
Harding Loevner
Bridgewater,
New Jersey
|
-$71.6M |
| 3 |
ClearBridge Investments
New York
|
-$33.4M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$33.2M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
-$26.4M |
